AU6270298A - Zonula occludens toxin receptors - Google Patents

Zonula occludens toxin receptors

Info

Publication number
AU6270298A
AU6270298A AU62702/98A AU6270298A AU6270298A AU 6270298 A AU6270298 A AU 6270298A AU 62702/98 A AU62702/98 A AU 62702/98A AU 6270298 A AU6270298 A AU 6270298A AU 6270298 A AU6270298 A AU 6270298A
Authority
AU
Australia
Prior art keywords
zonula occludens
occludens toxin
toxin receptors
receptors
zonula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62702/98A
Other languages
English (en)
Inventor
Alessio Fasano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland Baltimore
Original Assignee
University of Maryland Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/803,364 external-priority patent/US5864014A/en
Application filed by University of Maryland Baltimore filed Critical University of Maryland Baltimore
Publication of AU6270298A publication Critical patent/AU6270298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/909—Vibrio
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU62702/98A 1997-02-20 1998-02-18 Zonula occludens toxin receptors Abandoned AU6270298A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08803364 1997-02-20
US08/803,364 US5864014A (en) 1997-02-20 1997-02-20 Zonula occludens toxin receptor
US09024198 1998-02-17
US09/024,198 US5912323A (en) 1997-02-20 1998-02-17 Zonula occludens toxin receptors
PCT/US1998/002257 WO1998037096A1 (en) 1997-02-20 1998-02-18 Zonula occludens toxin receptors

Publications (1)

Publication Number Publication Date
AU6270298A true AU6270298A (en) 1998-09-09

Family

ID=26698164

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62702/98A Abandoned AU6270298A (en) 1997-02-20 1998-02-18 Zonula occludens toxin receptors

Country Status (9)

Country Link
US (2) US5912323A (enExample)
EP (1) EP1007553B1 (enExample)
JP (1) JP4215827B2 (enExample)
AT (1) ATE359294T1 (enExample)
AU (1) AU6270298A (enExample)
CA (1) CA2281617A1 (enExample)
DE (1) DE69837546T2 (enExample)
ES (1) ES2285762T3 (enExample)
WO (1) WO1998037096A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458925B1 (en) 1998-08-03 2002-10-01 University Of Maryland, Baltimore Peptide antagonists of zonulin and methods for use of the same
EP1249244A1 (en) * 2001-04-13 2002-10-16 Universiteit Gent Therapeutic compositions for the treatment of a disease modulated by the G-actin / F-actin equilibrium, especially a respiratory tract disease
US7452877B2 (en) 2002-03-15 2008-11-18 Rytek Methods for treating digestive functional pathologies
FR2844201A1 (fr) * 2002-09-06 2004-03-12 Rytek Compositions pour le traitement de pathologies fonctionnelles digestives
EP1546374B1 (en) 2002-09-06 2010-11-10 Promega Corporation Method for detecting transferase enzymatic activity
CA2508072A1 (en) 2002-12-23 2004-07-15 Promega Corporation Protecting luciferase activity from luciferase enzyme interfering compounds using detergents for the accurate measurement of luciferase activity
CA2531491A1 (en) * 2003-07-15 2005-02-03 University Of Maryland, Baltimore Agonist polypeptide of receptor for zot and zonulin
US20080038843A1 (en) * 2006-08-11 2008-02-14 University Of Maryland - Baltimore Method of diagnosing celiac disease
US8529889B2 (en) 2004-06-29 2013-09-10 Massachusetts Institute Of Technology Methods and compositions related to the modulation of intercellular junctions
FR2879100B1 (fr) 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
AR053661A1 (es) * 2005-01-14 2007-05-16 Univ Maryland Peptido para entregar vacunas via mucosas
AR057058A1 (es) * 2005-06-09 2007-11-14 Alba Therapeutics Corp Metodo para usar antagonistas de zonulina para prevenir la perdida o para regenerar celulas pancreaticas
MX2008010221A (es) 2006-02-09 2009-03-05 Alba Therapeutics Corp Formulaciones para un efector de union ajustada.
US20090069247A1 (en) * 2006-10-06 2009-03-12 Blake Paterson Use of tight junction antagonists to treat inflammatory bowel disease
WO2008052185A2 (en) * 2006-10-26 2008-05-02 Alba Therapeutics Corp Materials and methods for the treatment of celiac disease
EP2091551B1 (en) 2006-11-03 2020-01-15 Alba Therapeutics Corporation Method of treating asthma
WO2009023311A2 (en) * 2007-05-07 2009-02-19 Alba Therapeutics Corporation Transcutaneous delivery of therapeutic agents
US20110201543A1 (en) * 2007-06-29 2011-08-18 Blake Paterson Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress
WO2009015382A2 (en) 2007-07-26 2009-01-29 Alba Therapeutics Corporation Novel peptides that enhance tight junction permeability

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216126A (en) * 1991-06-19 1993-06-01 Genentech, Inc. Receptor polypeptides and their production and uses
US5665389A (en) * 1995-05-24 1997-09-09 University Of Maryland At Baltimore Oral dosage composition for intestinal delivery and method of treating diabetes

Also Published As

Publication number Publication date
DE69837546T2 (de) 2007-12-27
EP1007553A1 (en) 2000-06-14
ES2285762T3 (es) 2007-11-16
CA2281617A1 (en) 1998-08-27
WO1998037096A1 (en) 1998-08-27
US5948629A (en) 1999-09-07
EP1007553B1 (en) 2007-04-11
EP1007553A4 (en) 2004-09-22
JP4215827B2 (ja) 2009-01-28
JP2001518077A (ja) 2001-10-09
ATE359294T1 (de) 2007-05-15
US5912323A (en) 1999-06-15
DE69837546D1 (de) 2007-05-24

Similar Documents

Publication Publication Date Title
AU6270298A (en) Zonula occludens toxin receptors
AU5906398A (en) Dosage composition for nasal delivery and method of use of the same
WO1999003822A8 (en) Bicyclic metabotropic glutamate receptor ligands
EP1553975B8 (en) Optimized fc variants and methods for their generation
AU3553997A (en) Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
AU4968397A (en) Antipruritic
AU2003247798A1 (en) Nozzles and components thereof and methods for making the same
EP1208085A4 (en) BENZANILIDE AS THE OPENER OF THE POTASSIUM CHANNEL
AU3738597A (en) Molecular model for vla-4 inhibitors
AU6497600A (en) Peracid forming system, peracid forming composition, and methods for making and using
AU2482900A (en) 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
AU1613601A (en) Cleaning process which uses ultrasonic waves
AU4107300A (en) Polyurethane solutions containing alkoxysilane structural units
AU9744298A (en) Substituted tetrahydronaphthaline and analogous compounds
BG105009A (en) Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline
MXPA02001719A (es) METODOS, COMPOSICIONES Y EQUIPOS PARA PROMOVER LA RECUPERACION DEL DAnO AL SISTEMA NERVIOSO CENTRAL.
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
HUP9901794A3 (en) Administration regimen of h+,k+-atpase inhibitors
AU2100901A (en) Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
AU1044500A (en) Imidazonaphthyridines
AU7520898A (en) Tetrahydropyrido compounds
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
AUPO684997A0 (en) Polyphenol oxidase genes from banana, tobacco & pineapple
WO2001030330A3 (en) Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
EP0983243A4 (en) NOVEL QUINOLINE- AND NAPHTHALENECARBOXAMIDES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INHIBITING CALPAIN